Literature DB >> 16619530

Resveratrol suppresses angiogenesis in gliomas: evaluation by color Doppler ultrasound.

Jin-Cherng Chen1, Yun Chen, Jyh-Herng Lin, Jiann-Ming Wu, Sheng-Hong Tseng.   

Abstract

BACKGROUND: The effects of resveratrol (a natural polyphenol) on angiogenesis in rat gliomas were investigated by color Doppler ultrasound (CDUS). The correlation among the tumor growth rate, macroscopic angiogenesis measured by CDUS and microscopic angiogenesis was assessed by immunohistochemical staining.
MATERIALS AND METHODS: Fischer rats were subcutaneously inoculated with rat RT-2 glioma cells and treated with resveratrol for 4 weeks. The tumor size was measured and the animal survival followed. CDUS examination was used to measure tumor blood flow shown as the color Doppler vascularity index (CDVI). Immunohistochemical staining of CD31 was carried out to assess the microvessel density (MVD) of the tumors. The CDVI, MVD and tumor size were correlated.
RESULTS: Rats treated with resveratrol (40 mg/kg/day) had slower tumor growth rates than those of the control groups (p < 0.05). The CDVI, MVD and tumor size were significantly correlated (linear regression, p < 0.0001).
CONCLUSION: Resveratrol-suppressed glioma growth was significantly correlated with the inhibition of macroscopic and microscopic angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16619530

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  14 in total

Review 1.  Resveratrol: challenges in translation to the clinic--a critical discussion.

Authors:  Lalita Subramanian; Sherry Youssef; Saswati Bhattacharya; Jason Kenealey; Arthur S Polans; Paul R van Ginkel
Journal:  Clin Cancer Res       Date:  2010-11-02       Impact factor: 12.531

Review 2.  Resveratrol: Biological and pharmaceutical properties as anticancer molecule.

Authors:  Tze-chen Hsieh; Joseph M Wu
Journal:  Biofactors       Date:  2010 Sep-Oct       Impact factor: 6.113

Review 3.  The multifaceted NF-kB: are there still prospects of its inhibition for clinical intervention in pediatric central nervous system tumors?

Authors:  Mariana Medeiros; Marina Ferreira Candido; Elvis Terci Valera; María Sol Brassesco
Journal:  Cell Mol Life Sci       Date:  2021-07-31       Impact factor: 9.261

4.  Resveratrol, a multitargeted agent, can enhance antitumor activity of gemcitabine in vitro and in orthotopic mouse model of human pancreatic cancer.

Authors:  Kuzhuvelil B Harikumar; Ajaikumar B Kunnumakkara; Gautam Sethi; Parmeswaran Diagaradjane; Preetha Anand; Manoj K Pandey; Juri Gelovani; Sunil Krishnan; Sushovan Guha; Bharat B Aggarwal
Journal:  Int J Cancer       Date:  2010-07-15       Impact factor: 7.396

5.  Resveratrol and its synthetic derivatives exert opposite effects on mesothelial cell-dependent angiogenesis via modulating secretion of VEGF and IL-8/CXCL8.

Authors:  Justyna Mikuła-Pietrasik; Angelika Kuczmarska; Małgorzata Kucińska; Marek Murias; Marcin Wierzchowski; Marek Winckiewicz; Ryszard Staniszewski; Andrzej Bręborowicz; Krzysztof Książek
Journal:  Angiogenesis       Date:  2012-03-27       Impact factor: 9.596

6.  Resveratrol: French paradox revisited.

Authors:  Betul Catalgol; Saime Batirel; Yavuz Taga; Nesrin Kartal Ozer
Journal:  Front Pharmacol       Date:  2012-07-17       Impact factor: 5.810

7.  Anti-angiogenic effects of resveratrol mediated by decreased VEGF and increased TSP1 expression in melanoma-endothelial cell co-culture.

Authors:  Valerie Trapp; Basmina Parmakhtiar; Vartan Papazian; Lyndsay Willmott; John P Fruehauf
Journal:  Angiogenesis       Date:  2010-10-07       Impact factor: 9.596

8.  The sustained delivery of resveratrol or a defined grape powder inhibits new blood vessel formation in a mouse model of choroidal neovascularization.

Authors:  Mozhgan Rezaie Kanavi; Soesiawati Darjatmoko; Shoujian Wang; Amir A Azari; Mitra Farnoodian; Jason D Kenealey; Paul R van Ginkel; Daniel M Albert; Nader Sheibani; Arthur S Polans
Journal:  Molecules       Date:  2014-10-30       Impact factor: 4.411

9.  Polydatin inhibits growth of lung cancer cells by inducing apoptosis and causing cell cycle arrest.

Authors:  Yusong Zhang; Zhixiang Zhuang; Qinghui Meng; Yang Jiao; Jiaying Xu; Saijun Fan
Journal:  Oncol Lett       Date:  2013-11-21       Impact factor: 2.967

10.  Sirt1 Is Required for Resveratrol-Mediated Chemopreventive Effects in Colorectal Cancer Cells.

Authors:  Constanze Buhrmann; Parviz Shayan; Bastian Popper; Ajay Goel; Mehdi Shakibaei
Journal:  Nutrients       Date:  2016-03-05       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.